title: The interferon sensitivity determining region in the era of combination therapies and the rational use of such therapies for patients with HCV genotype 1b infection.
authors.forename: Hisashi
authors.initials: H
authors.lastname: Moriguchi
authors.forename: Raymond T
authors.initials: RT
authors.lastname: Chung
authors.forename: Ana Maria
authors.initials: AM
authors.lastname: Contreras
authors.forename: Namiki
authors.initials: N
authors.lastname: Izumi
authors.forename: Takamoto
authors.initials: T
authors.lastname: Uemura
authors.forename: Makoto
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Chifumi
authors.initials: C
authors.lastname: Sato
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D011994:Recombinant Proteins; D007372:Interferons